Format
Items per page
Sort by

Send to:

Choose Destination

Results: 18

Cited In for PubMed (Select 20539725)

1.

Economic evaluation of first-line and maintenance treatments for advanced non-small cell lung cancer: a systematic review.

Chouaïd C, Crequit P, Borget I, Vergnenegre A.

Clinicoecon Outcomes Res. 2014 Dec 15;7:9-15. doi: 10.2147/CEOR.S43328. eCollection 2015. Review.

3.

From the first visit on: information technology and communication.

Hoverman JR.

J Oncol Pract. 2013 May;9(3):152-4. doi: 10.1200/JOP.2013.000974. Review. No abstract available.

4.

Accountable care organizations and the practice of oncology.

Bernstein SJ.

J Oncol Pract. 2013 May;9(3):122-4. doi: 10.1200/JOP.2013.001032. Review. No abstract available.

5.

Doing palliative care in the oncology office.

Cheng MJ, King LM, Alesi ER, Smith TJ.

J Oncol Pract. 2013 Mar;9(2):84-8. doi: 10.1200/JOP.2013.000885.

6.

Promise and perils of guidelines in quality cancer care.

Irwin B, Peppercorn J.

J Oncol Pract. 2012 Nov;8(6):354-7. doi: 10.1200/JOP.2012.000618. Epub 2012 Jul 17. No abstract available.

7.

Clinical pathways for inborn errors of metabolism: warranted and feasible.

Demirdas S, van Kessel IN, Korndewal MJ, Hollak CE, Meutgeert H, Klaren A, van Rijn M, van Spronsen FJ, Bosch AM; Dutch working Group.

Orphanet J Rare Dis. 2013 Feb 25;8:37. doi: 10.1186/1750-1172-8-37.

8.

Translating genomic information into clinical medicine: lung cancer as a paradigm.

Levy MA, Lovly CM, Pao W.

Genome Res. 2012 Nov;22(11):2101-8. doi: 10.1101/gr.131128.111. Epub 2012 Sep 27.

9.

Partnering With a Payer to Develop a Value-Based Medical Home Pilot: A West Coast Practice's Experience.

Bosserman LD, Verrilli D, McNatt W.

J Oncol Pract. 2012 May;8(3 Suppl):38s-40s. doi: 10.1200/JOP.2012.000591.

10.

Survival among non-small cell lung cancer patients with poor performance status after first line chemotherapy.

Salloum RG, Smith TJ, Jensen GA, Lafata JE.

Lung Cancer. 2012 Sep;77(3):545-9. doi: 10.1016/j.lungcan.2012.04.019. Epub 2012 May 26.

11.

Patterns of care for non-small-cell lung cancer at an academic institution affiliated with a national cancer institute-designated cancer center.

Nguyen KS, Sanford RA, Huberman MS, Goldstein MA, McDonald DM, Farquhar M, Gangadharan SP, Kent MS, Michaud G, Majid A, Berman SM, Aronovitz JA, Nedea EA, Boiselle PM, Cohen DW, Kobayashi S, Costa DB.

J Oncol Pract. 2012 Jan;8(1):57-62. doi: 10.1200/JOP.2011.000274. Epub 2011 Nov 22.

13.

Benchmarks for value in cancer care: an analysis of a large commercial population.

Kolodziej M, Hoverman JR, Garey JS, Espirito J, Sheth S, Ginsburg A, Neubauer MA, Patt D, Brooks B, White C, Sitarik M, Anderson R, Beveridge R.

J Oncol Pract. 2011 Sep;7(5):301-6. doi: 10.1200/JOP.2011.000394.

14.

Pathways, outcomes, and costs in colon cancer: retrospective evaluations in two distinct databases.

Hoverman JR, Cartwright TH, Patt DA, Espirito JL, Clayton MP, Garey JS, Kopp TJ, Kolodziej M, Neubauer MA, Fitch K, Pyenson B, Beveridge RA.

J Oncol Pract. 2011 May;7(3 Suppl):52s-9s. doi: 10.1200/JOP.2011.000318.

15.

Report on the ASCO 2010 Provider-Payer Initiative Meeting.

Neuss MN, Flamm C, Shulman LN, Tomkins JE, Ward JC.

J Oncol Pract. 2011 May;7(3):136-40. doi: 10.1200/JOP.2011.000279.

16.

Transition from curative to palliative care in cancer.

Kaur J, Mohanti BK.

Indian J Palliat Care. 2011 Jan;17(1):1-5. doi: 10.4103/0973-1075.78442. No abstract available.

17.

Bending the cost curve in cancer care.

Smith TJ, Hillner BE.

N Engl J Med. 2011 May 26;364(21):2060-5. doi: 10.1056/NEJMsb1013826. No abstract available.

18.

Reducing cancer costs and improving quality through collaboration with payers: a proposal from the Florida society of clinical oncology.

Marsland T, Robbins G, Marks A, Cassell R, Philips DG, King K.

J Oncol Pract. 2010 Sep;6(5):265-9. doi: 10.1200/JOP.000062.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk